Industry Supported Session
The body of evidence supporting the need for multimodal monitoring in traumatic brain injury is growing. Recently, the feasibility of utilizing a treatment protocol based on intracranial pressure (ICP) and brain tissue oxygen (PbtO2) monitoring was evaluated in the BOOST-2 trial published in 2017, and the ongoing BOOST-3 study, an RCT that will determine the safety and efficacy of a strategy guided by treatment goals based on both ICP and PbtO2 as compared to a strategy based on ICP monitoring alone.
Please join Dr. Francis Bernard, an Investigator for BOOST-3, as he discusses the published research and protocols regarding multimodal monitoring, and his application of these principles in real world ICU patients.
This program was developed by the CNSF and Integra and was planned to achieve scientific integrity, objectivity and balance. It is an unaccredited learning activity and not eligible for MOC credits.
Faculty: Francis Bernard